Sponsor pipeline

NaviFUS Corporation clinical trial pipeline

4 active trials 4 recruiting 1 Phase 3 3 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 1/2		2
Phase 3		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06496971	A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab…	Glioblastoma Multiforme	Recruiting	2026-04-09
Phase 1/2
NCT06329570	Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment…	Glioblastoma Multiforme	Recruiting	2026-04-09
NCT06388707	A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound…	Drug Resistant Epilepsy	Recruiting	2026-04-09
Not applicable
NCT06492720	A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating…	Drug Resistant Epilepsy	Recruiting	2026-04-09

Get alerts when NaviFUS Corporation's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.